Bajaj HealthCare Limited
NSE: BAJAJHCARE BSE: BAJAJHCARE
NSE
521.10
-32.90 (-5.94%)
Prev Close
554
Open Price
546.35
Volume
613,420
Today Low / High
514.85 / 553.95
52 WK Low / High
263.3 / 745
Range
495 - 547
BSE
522.75
-32.50 (-5.85%)
Prev Close
555.25
Open Price
550
Volume
114,093
Today Low / High
515.1 / 551.15
52 WK Low / High
265 / 744.9
Range
497 - 549
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 521.1 (target range: 495 - 547), reflecting a change of -32.9 (-5.93863%). On the BSE, it is listed at 522.75 (target range: 497 - 549), showing a change of -32.5 (-5.85322%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
30 Apr
546.35
-4.62%
29 Apr
578.00
-4.15%
28 Apr
575.00
0.02%
25 Apr
620.10
-4.60%
24 Apr
627.90
-0.89%
23 Apr
619.95
0.76%
22 Apr
621.90
-1.35%
21 Apr
624.95
-0.73%
17 Apr
623.95
-0.29%
16 Apr
622.75
-0.14%
15 Apr
596.95
4.10%
11 Apr
589.75
-1.82%
09 Apr
573.00
-1.92%
08 Apr
584.00
-0.47%
07 Apr
503.50
13.07%
04 Apr
667.20
-11.05%
03 Apr
661.00
0.88%
Bajaj HealthCare Limited Graph
Bajaj HealthCare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Bajaj HealthCare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 521.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 522.75 | 527.98 | 475.18 - 580.78 |
| 533.21 | 426.56 - 639.85 | ||
| 538.43 | 376.90 - 699.96 | ||
| Bearish Scenario | 522.75 | 517.52 | 465.77 - 569.27 |
| 512.30 | 409.84 - 614.75 | ||
| 507.07 | 354.95 - 659.19 |
Overview of Bajaj HealthCare Limited
ISIN
INE411U01027
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
386,267
Market Cap
16,458,057,630
Last Dividend
1
Official Website
IPO Date
2021-11-25
DCF Diff
1,332.02
DCF
-665
Financial Ratios Every Investor Needs
Stock Dividend of BAJAJHCARE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-23 | September 23, 24 | 1 | 1 | 2024-09-23 | 2024-10-30 | |
| 2023-09-22 | September 22, 23 | 1 | 1 | 2023-09-23 | 2023-10-30 | |
| 2022-09-22 | September 22, 22 | 1.5 | 1.5 | 2022-09-23 | 2022-10-30 | |
| 2021-09-28 | September 28, 21 | 0.5 | 0.5 | 2021-09-29 | 2021-10-30 | |
| 2020-12-01 | December 01, 20 | 1.75 | 1.75 | 2020-12-02 | 2020-12-15 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 473.42 Cr | 259.13 Cr | 214.29 Cr | 0.4526 | 1.63 Cr | 5.74 Cr | 48.71 Cr | -83.79 Cr | -30.36 | 40.62 Cr | -0.1770 |
| 2023-03-31 | 673.29 Cr | 490.66 Cr | 182.64 Cr | 0.2713 | 3.80 Cr | 47.84 Cr | 82.19 Cr | 43.02 Cr | 15.59 | 112.95 Cr | 0.0639 |
| 2022-03-31 | 679.22 Cr | 495.39 Cr | 183.84 Cr | 0.2707 | 2.61 Cr | 6.96 Cr | 104.32 Cr | 71.39 Cr | 25.87 | 121.95 Cr | 0.1051 |
| 2021-03-31 | 655.78 Cr | 462.93 Cr | 192.86 Cr | 0.2941 | 4.53 Cr | 5.57 Cr | 122.58 Cr | 83.11 Cr | 30.11 | 138.70 Cr | 0.1267 |
| 2020-03-31 | 359.26 Cr | 264.44 Cr | 94.82 Cr | 0.2639 | 2.23 Cr | 2.72 Cr | 43.36 Cr | 25.24 Cr | 9.14 | 55.49 Cr | 0.0702 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 2.17 Cr | 765.13 Cr | 486.77 Cr | 278.3609 Cr | 332.82 Cr | 330.65 Cr | 144.04 Cr | 257.56 Cr | 0.31 Cr | 0.00 Cr | 1.95 Cr | 441.4792 Cr |
| 2023-03-31 | 17.72 Cr | 901.46 Cr | 533.77 Cr | 367.6894 Cr | 415.24 Cr | 397.52 Cr | 208.79 Cr | 387.42 Cr | 28.29 Cr | 2.79 Cr | 0.00 Cr | 436.0596 Cr |
| 2022-03-31 | 1.98 Cr | 721.10 Cr | 392.62 Cr | 328.4855 Cr | 256.74 Cr | 254.76 Cr | 159.26 Cr | 321.72 Cr | 25.56 Cr | 68.98 Cr | 0.00 Cr | 322.0730 Cr |
| 2021-03-31 | 14.24 Cr | 525.63 Cr | 267.22 Cr | 258.4105 Cr | 180.89 Cr | 166.64 Cr | 97.11 Cr | 265.18 Cr | 10.95 Cr | 2.78 Cr | 0.00 Cr | 182.5733 Cr |
| 2020-03-31 | 4.16 Cr | 325.75 Cr | 174.14 Cr | 151.6062 Cr | 90.93 Cr | 86.77 Cr | 39.28 Cr | 140.17 Cr | 31.07 Cr | 25.67 Cr | 5.00 Cr | 146.2657 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 92.2944 Cr | -11.2446 Cr | -54.7200 Cr | 62.0081 Cr | -15.5457 Cr | 2.1747 Cr | -30.2863 Cr | -14.3266 Cr | -51.7296 Cr | -2.7598 Cr | 20.4204 Cr |
| 2023-03-31 | -22.3237 Cr | -93.4267 Cr | 131.4958 Cr | -146.1657 Cr | 15.7454 Cr | 17.7204 Cr | -123.8420 Cr | 58.2163 Cr | 45.1596 Cr | -4.1398 Cr | -49.5249 Cr |
| 2022-03-31 | 0.6860 Cr | -74.7984 Cr | 61.8463 Cr | -78.6189 Cr | -12.2662 Cr | 1.9749 Cr | -79.3049 Cr | 89.6846 Cr | -11.8824 Cr | -1.3800 Cr | -62.1515 Cr |
| 2021-03-31 | 43.5583 Cr | -108.9330 Cr | 75.4573 Cr | -70.2304 Cr | 10.0826 Cr | 14.2411 Cr | -113.7887 Cr | 118.8197 Cr | 56.1351 Cr | -2.4149 Cr | -57.8352 Cr |
| 2020-03-31 | 20.5749 Cr | -27.5602 Cr | 3.2823 Cr | -2.1145 Cr | -3.7030 Cr | 4.1585 Cr | -22.6894 Cr | 32.4513 Cr | 6.1855 Cr | 0.0000 Cr | -9.2272 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 122.79 Cr | 60.91 Cr | 61.88 Cr | 0.5039 | 14.79 Cr | 11.72 Cr | 3.65 | 24.01 Cr | 0.0955 |
| 2024-09-30 | 133.09 Cr | 65.98 Cr | 67.11 Cr | 0.5042 | 17.72 Cr | 9.46 Cr | 3.36 | 27.13 Cr | 0.0711 |
| 2024-06-30 | 132.25 Cr | 85.02 Cr | 47.23 Cr | 0.3571 | 53.96 Cr | 7.13 Cr | 2.58 | 24.50 Cr | 0.0539 |
| 2024-03-31 | 133.90 Cr | 101.61 Cr | 32.29 Cr | 0.2411 | 8.74 Cr | -29.92 Cr | -10.84 | -21.84 Cr | -0.2235 |
| 2023-12-31 | 108.57 Cr | 51.29 Cr | 57.28 Cr | 0.5276 | 12.98 Cr | -2.20 Cr | -0.80 | 20.33 Cr | -0.0202 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 21.47 Cr | 36.53 Cr | 58.00 Cr | 0.00 Cr | 142.43 Cr | 531.07 Cr | 248.29 Cr | 803.95 Cr | 358.12 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 2.93 Cr | 0.00 Cr | 0.00 Cr | 2.93 Cr | 0.00 Cr | 0.00 Cr | -278.36 Cr |
| 2024-03-31 | 2.93 Cr | 35.78 Cr | 2.93 Cr | 180.24 Cr | 144.04 Cr | 404.54 Cr | 257.56 Cr | 765.13 Cr | 486.77 Cr |
| 2023-12-31 | -10.34 Cr | 20.68 Cr | 10.34 Cr | 0.00 Cr | 0.00 Cr | 10.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 5.51 Cr | 5.73 Cr | 11.24 Cr | 219.92 Cr | 202.79 Cr | 567.50 Cr | 257.00 Cr | 837.91 Cr | 521.77 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 7.13 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -29.92 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -2.20 Cr | 14.71 Cr | 0.00 Cr | 0.00 Cr | 14.71 Cr | 25.05 Cr | 10.34 Cr | 0.00 Cr | 14.71 Cr |
| 2023-09-30 | -3.46 Cr | 13.32 Cr | 0.00 Cr | 0.00 Cr | 13.32 Cr | 10.34 Cr | -2.98 Cr | 0.00 Cr | 13.32 Cr |
| 2023-06-30 | -48.21 Cr | 12.61 Cr | 0.00 Cr | 0.00 Cr | 12.61 Cr | 30.33 Cr | 17.72 Cr | 0.00 Cr | 12.61 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,832.30 | ₹4,396,200,744,000.00 | ₹2,667,255.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,087.00 | ₹1,615,909,803,000.00 | ₹489,351.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,322.00 | ₹1,124,314,290,000.00 | ₹1,148,932.00 |
| Mankind Pharma Limited | MANKIND | ₹2,465.30 | ₹1,017,129,825,356.00 | ₹734,502.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,183.90 | ₹986,322,504,378.00 | ₹1,604,381.00 |
| Lupin Limited | LUPIN | ₹2,095.60 | ₹956,777,614,000.00 | ₹1,018,558.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹888.25 | ₹893,783,797,500.00 | ₹907,406.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,229.10 | ₹713,863,738,200.00 | ₹1,099,893.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,116.00 | ₹611,694,540,000.00 | ₹114,595.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,381.20 | ₹389,758,065,600.00 | ₹694,494.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,401.20 | ₹355,490,044,800.00 | ₹474,031.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,706.10 | ₹338,024,363,200.00 | ₹96,394.00 |
| Laurus Labs Limited | LAURUSLABS | ₹603.85 | ₹325,627,924,050.00 | ₹4,019,120.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,137.10 | ₹289,465,861,500.00 | ₹121,688.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,612.40 | ₹251,013,594,800.00 | ₹277,371.00 |
| Piramal Enterprises Limited | PEL | ₹967.95 | ₹218,251,430,100.00 | ₹335,521.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,681.00 | ₹217,025,000,000.00 | ₹11,915.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,296.70 | ₹210,686,519,300.00 | ₹399,606.00 |
| Eris Lifesciences Limited | ERIS | ₹1,432.10 | ₹194,999,032,300.00 | ₹107,678.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹875.55 | ₹172,100,734,650.00 | ₹244,336.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹11,992.00 | ₹153,856,160,800.00 | ₹29,263.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹850.90 | ₹152,404,699,000.00 | ₹706,128.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹897.95 | ₹143,026,373,950.00 | ₹278,779.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,878.90 | ₹142,818,383,130.00 | ₹124,383.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹455.80 | ₹110,551,555,200.00 | ₹1,020,915.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,082.00 | ₹84,358,150,800.00 | ₹7,156.00 |
| FDC Limited | FDC | ₹421.00 | ₹68,543,010,000.00 | ₹88,567.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹713.35 | ₹64,654,206,177.00 | ₹195,788.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹647.05 | ₹63,275,601,845.00 | ₹157,392.00 |
| Strides Pharma Science Limited | STAR | ₹649.90 | ₹59,896,538,730.00 | ₹364,471.00 |
| Innova Captab Limited | INNOVACAP | ₹884.55 | ₹50,618,311,832.00 | ₹26,896.00 |
| Hikal Limited | HIKAL | ₹387.75 | ₹47,809,962,750.00 | ₹225,536.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹145.95 | ₹47,363,985,900.00 | ₹354,129.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹602.40 | ₹42,412,453,920.00 | ₹14,879.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹801.00 | ₹40,625,999,100.00 | ₹36,713.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹367.70 | ₹36,872,220,600.00 | ₹34,907.00 |
| Sequent Scientific Limited | SEQUENT | ₹144.10 | ₹36,068,518,200.00 | ₹345,447.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,091.30 | ₹34,588,010,700.00 | ₹41,516.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹60.17 | ₹32,970,392,180.00 | ₹6,133,715.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹349.00 | ₹31,853,230,000.00 | ₹244,284.00 |
| Suven Life Sciences Limited | SUVEN | ₹127.50 | ₹27,804,435,000.00 | ₹223,680.00 |
| Alembic Limited | ALEMBICLTD | ₹99.96 | ₹25,667,928,620.00 | ₹508,176.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹493.85 | ₹24,648,799,214.00 | ₹113,723.00 |
Key Executives
Senior Vice President of Operations and Unit II Head- Salvi
Mr. Nandkumar R. Soni
Gender: male
Year Born:
Whole Time Director
Mr. Pakshal Anil Jain
Gender: male
Year Born: 1998
Chief Technical Officer
Mr. Amit Rajan M.Tech
Gender: male
Year Born:
Company Secretary & Compliance Officer
Ms. Monica Tanwar
Gender: female
Year Born:
Executive Vice President Sales & Marketing
Mr. A.G. Prasad
Gender: male
Year Born:
Whole-Time Director
Mr. Dhananjay Sabaji Hatle
Gender: male
Year Born: 1972
Whole Time Director
Ms. Namrata Sajankumar Bajaj
Gender: female
Year Born: 1986
Founder, Chairman & MD
Mr. Sajankumar Rameshwarlal Bajaj
Gender: male
Year Born: 1960
Vice Chairman & Joint MD
Mr. Anil Champalal Jain
Gender: male
Year Born: 1975
FAQs about Bajaj HealthCare Limited
Who is the CEO of the company?
The CEO is Mr. Sajankumar Rameshwarlal Bajaj.
What is the current market price of the stock?
The current price is ₹521.10.
What is the 52-week price range?
The range is ₹263.3-745.
What is the market capitalization of the company?
The market capitalization is ₹1,645.81 crores.
What is the dividend yield?
The dividend yield is 0.19%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -1,041.32.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Bajaj HealthCare Limited (ISIN: INE411U01027) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹1,645.81 crores and an average daily volume of 386,267 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹1.